Glaucoma Treatment and Hydrogel: Current Insights and State of the Art

Gels. 2022 Aug 17;8(8):510. doi: 10.3390/gels8080510.

Abstract

Aqueous gels formulated using hydrophilic polymers (hydrogels) and those based on stimuli-responsive polymers (in situ gelling or gel-forming systems) attract increasing interest in the treatment of several eye diseases. Their chemical structure enables them to incorporate various ophthalmic medications, achieving their optimal therapeutic doses and providing more clinically relevant time courses (weeks or months as opposed to hours and days), which will inevitably reduce dose frequency, thereby improving patient compliance and clinical outcomes. Due to its chronic course, the treatment of glaucoma may benefit from applying gel technologies as drug-delivering systems and as antifibrotic treatment during and after surgery. Therefore, our purpose is to review current applications of ophthalmic gelling systems with particular emphasis on glaucoma.

Keywords: drug delivery; glaucoma; glaucoma therapy; glaucoma treatment; hydrogel; hydrogel in glaucoma; hydrogel in ophthalmology; nanoparticles; ophthalmology.

Publication types

  • Review

Grants and funding

This research received no external funding.